Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish
Farmovs
In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19. 

The trial is expected to include more than 45 countries worldwide, including a number of South African sites. 

Farmovs

FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.   

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients. 

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.  FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.


News Archive

UFS council approves guidelines for reconfiguration of Vista Campus
2005-03-15

Human resource development (teaching and training) will be the primary aim of services to be rendered at the reconfigured Vista campus of the University of the Free State (UFS).

This in-principle decision forms part of a set of guidelines for the strategic reconfiguration of the Vista campus in Bloemfontein that was recently approved by the UFS Council.  The Vista campus was incorporated into the UFS in January 2004.

“One of the most important aspects that resulted from these guidelines is that we have come to a point where I can say that the future of staff at Vista is not dependant on the strategic reconfiguration of the campus.  Vista staff members will stay staff of the UFS and are being integrated into the functions of the main campus,” said Prof Magda Fourie, Vice-Rector:  Academic Planning at the UFS.

“According to the guidelines, the reconfiguration of the Vista campus must occur within the ambit of the UFS as a single institution with three campuses,” said Prof Fourie.

The UFS is currently offering two activities on the Vista campus – the regional Centre for Recognition of Prior Learning (RPL) and the Sesotho Language Research and Development Centre. 

According to Prof Fourie no duplication of services or programmes being rendered on the main campus in Bloemfontein will take place.  In the guidelines suggestions are made that the Vista campus could be used for activities that are currently offered on the main campus (eg short learning programmes), new UFS activities (mainly of a developmental and entrepreneurial nature), cooperative partnership ventures with other role-players and the renting of facilities for education and training purposes. 

“However, no definite decisions have been made about these possible activities – the necessary consultation process with relevant stakeholders and role-players must first take place.  A consultative forum for this will be established early in the second term of this year,” said Prof Fourie.

 “We are excited about the possibilities that have arised from the guidelines as it fits in with our vision to utilise new resources for education and training and to contribute to higher education in the Free State.  This will also contribute to the development of human resources as a propelling force in the Central Region,” said Prof Fourie.
 

MEDIA RELEASE
Issued by: Lacea Loader
Media Representative
Tel:  (051) 401-2584
Cell:  083 645 2454
E-mail:  loaderl.stg@mail.uovs.ac.za
15 March 2005

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept